Figure 3
30-Day outcomes (extubation, mortality, and tracheostomy) of the trajectory subphenotypes. (a) 30-day outcomes of subphenotypes derived in NYP-WCMC cohort. (b) 30-day outcomes of subphenotypes derived in NYP-LMH validation cohort. Chi-square/Fisher’s exact tests were applied to compare 30-day outcomes between the worsening and recovering subphenotypes for each baseline strata. *Denoting testing significance passed p-value < 0.05; **denoting testing significance passed p-value < 0.01; ***denoting testing significance passed p-value < 0.001. WA worsening subphenotype alive, RA recovering subphenotype alive, WE worsening subphenotype extubated, RE recovering subphenotype extubated.
